Hence, we consequently conducted mIHC staining [52] on microarrays comprising tumor tissues from 144 glioma patients and brain tissues from 3 normal human in order to assess the expression levels of DNM1L/DRP1, p-DNM1LSer616 (the positive style of DNM1L/DRP1), p-DNM1LSer637 (the negative style of DNM1L/DRP1), MFF, and FIS1 (Fig. 2c). This evidence concerns the gene DNM1L and central nervous system cancer.